Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2013
08/15/2013WO2013118130A1 A process for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene carboxamide
08/15/2013WO2013117649A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
08/15/2013WO2013117645A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
08/15/2013WO2013117522A1 Aurora and flt3 kinases modulators
08/15/2013WO2013042135A8 Heteroaryl compounds as 5-ht4 receptor ligands
08/15/2013US20130211087 7-aza-spiro[3,5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
08/15/2013US20130211079 Substituted heterocycles as therapeutic agents for treating cancer
08/15/2013US20130210818 Novel Heterocyclic Compounds and Uses Thereof
08/15/2013US20130210814 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
08/15/2013US20130210805 Quinazolinone-type compounds as crth2 antagonists
08/15/2013US20130210800 Pyridine-2-derivatives as smoothened receptor modulators
08/15/2013US20130210797 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
08/15/2013US20130210796 Tetrazole compounds as calcium channel blockers
08/15/2013US20130210773 Indole compounds as positive allosteric modulators of the muscarinic receptor
08/15/2013US20130209521 Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them
08/14/2013EP2626947A1 Photoelectric conversion element, pigment for photoelectric conversion element and compound
08/14/2013EP2626354A1 Viral polymerase inhibitors
08/14/2013EP2625185A2 Anti-inflammatory macrolides
08/14/2013EP2625178A1 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls
08/14/2013EP2625177A1 Novel gpr 119 agonists
08/14/2013EP2625170A1 1,4-oxazepane derivatives
08/14/2013EP2624696A1 Benzimidazole derivatives as pi3 kinase inhibitors
08/14/2013CN103249732A Bacteria topoisomerase II inhibiting 2-thylcarbamoylamino-1, 3-benzothiazol-5-yls
08/14/2013CN103249731A Hepatitis c virus inhibitors
08/14/2013CN103249728A Novel triazole compounds III
08/14/2013CN103249727A New biaryl amide derivatives
08/14/2013CN103249721A Arylamide derivatives as TTX-S blockers
08/14/2013CN103249718A 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres
08/14/2013CN103249414A Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
08/14/2013CN103249413A Hydroxylated aminotriazole derivatives as ALX receptor agonists
08/14/2013CN103242307A Crystal form I of oxazolidinone derivative as well as preparation method and application of crystal form I
08/14/2013CN103242306A Bacteria nitroreductase detection kit and special-purpose fluorescence probe thereof
08/14/2013CN103242305A Azilsartan preparation method
08/14/2013CN103242219A 2,6-diketone-piperazine (piperidine) type derivative and application thereof
08/14/2013CN102123988B Squaric acid derivatives as inhibitors of nicotinamide
08/14/2013CN101993415B Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof
08/14/2013CN101945879B Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
08/14/2013CN101691366B Quinoxaline derivative, and light-emitting element and electronic device using the same
08/14/2013CN101646656B Pyrimidine hydrazide compounds as PGDS inhibitors
08/14/2013CN101490038B Pyrimidine derivatives as ALK-5 inhibitors
08/14/2013CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors
08/14/2013CN101460495B Compound having heterocyclic ring
08/13/2013US8507722 Hepatitis C virus inhibitors
08/13/2013US8507540 Oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, and method for treating pathogenic bacterial infections using the same
08/13/2013US8507521 Heterocyclic derivatives
08/13/2013US8507514 Hydrazide compound and use of the same in pest control
08/13/2013US8507484 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases
08/13/2013US8507483 1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation
08/13/2013US8507480 Isoxazole compounds as inhibitors of heat shock proteins
08/13/2013CA2670892C Substituted diazepan compounds as orexin receptor antagonists
08/13/2013CA2619448C 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
08/13/2013CA2589102C Pyridazine compounds and methods for using the compounds to treat inflammatory diseases
08/08/2013WO2013116236A1 Process for the preparation of chiral isoxazoline azetidine derivatives as antiparasitic agents
08/08/2013WO2013116182A1 Heterocyclic compounds as inhibitors of leukotriene production
08/08/2013WO2013115535A1 Novel crystalline acid addition salt of tricyclo derivative compound or hydride thereof, and production method therefor
08/08/2013WO2013114326A1 Process for preparing taxol derivatives and certain intermediate compounds
08/08/2013WO2013114305A1 Process for the preparation of azilsartan medoxomil or pharmaceutically acceptable salts thereof
08/08/2013WO2013113841A1 Novel therapeutic agents
08/08/2013WO2013113669A1 Isoquinoline and naphthyridine derivatives
08/08/2013WO2013083975A3 Novel pyrrole derivatives
08/08/2013US20130203995 Process for Making a Metabotropic Glutamate Receptor Positive Allosteric Modulator - 874
08/08/2013US20130203987 Ampk-activating heterocyclic compounds and methods for using the same
08/08/2013US20130203985 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
08/08/2013US20130203904 Sterically hindered polymeric amines and their use as polymer stabilizers
08/08/2013US20130203818 Compounds that modulate intracellular calcium
08/08/2013US20130203817 Novel Inhibitors of LYN Kinase
08/08/2013US20130203772 Polymorphs and Salts
08/08/2013US20130203758 Compounds for the Treatment of Hepatitis C
08/08/2013US20130203756 Isoindoline pde10 inhibitors
08/08/2013US20130203750 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
08/08/2013US20130203749 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
08/08/2013US20130203747 Inhibitors of human immunodeficiency virus replication
08/08/2013US20130203735 Caprolactam mglur5 receptor modulators
08/08/2013US20130203656 Inhibitors of hcv ns5a
08/08/2013US20130203593 Pesticidal compositions and processes related thereto
08/08/2013US20130203592 Pesticidal compositions and processes related thereto
08/07/2013EP2623493A1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators
08/07/2013EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
08/07/2013EP2621924A1 Herbicidal benzoxazinones
08/07/2013EP2621920A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
08/07/2013EP2621905A2 Methods including latent 1,3-dipole-functional compounds and materials prepared thereby
08/07/2013CN103237795A Substituted oxadiazole compounds and their use as S1P1 agonists
08/07/2013CN103237794A P2X4 receptor antagonist
08/07/2013CN103232446A Oxazolidinone derivative crystal form II and preparation method and application thereof
08/07/2013CN103232445A Method for preparing nifuratel
08/07/2013CN103232444A Naphthoquine derivatives, and preparation and application thereof
08/07/2013CN102056902B Imidazolidine derivatives
08/07/2013CN101679366B Pyridyl piperidine orexin receptor antagonists
08/07/2013CN101595102B Biaryl ether urea compounds
08/07/2013CN101212969B Azinone and diazinone V3 inhibitors for depression and stress disorders
08/06/2013US8501938 Benzothiazole derivatives
08/06/2013US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/06/2013US8501786 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
08/06/2013US8501784 2-pyridone derivatives as neutrophil elastase inhibitors and their use
08/06/2013US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
08/06/2013US8501774 Oxazolidinone-quinolone hybrid antibiotics
08/06/2013US8501773 4-fluoro-piperidine T-type calcium channel antagonists
08/06/2013US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/06/2013US8501732 Aminomethyl quinolone compounds
08/06/2013US8501731 Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 647